The impact of COVID-19 pandemics on dermatologic surgery: real-life data from the Italian Red-Zone

Abstract

Background: The COVID-19 pandemic is challenging healthcare systems worldwide. Dermatology had to re-prioritize visits, guarantee urgent care, and ensure continuity for chronic patients. Objectives: To evaluate the COVID-19 impact on dermatologic surgery outpatient management. Material and methods: In this real-life retrospective observational study, we evaluated both major and minor outpatient surgeries (MaOS and MiOS) performance in 2020, before and during the first month of lockdown declaration, in a primary referral center in Northern Italy. During the lockdown, all lifesaving and cancer surgery, (approximately 80% of our usual activities), were continued. Data from 2020 were compared with the 2019 corresponding periods to assess the real-life impact of COVID-19 in dermatologic surgical activities. Results: From January 1st to April 3rd, 2020 we performed 769 interventions, compared to 908 over the corresponding 2019 period. After the lockdown, scheduled surgeries were reduced by 14.8%; overall performed ones displayed a reduction of 46.5% (51.6% MaOS, 44.2% MiOS). 52.9% and 12.5% procedures were canceled due to patients' renunciation and due to confirmed/suspected COVID-19, respectively. Conclusions: While reduced in number, dermatologic surgeries, similarly to other surgical specialties, remained operative to provide oncological and/or life-saving procedures.

Assessment of the Impact of COVID-19 pandemic on population level interest in Skincare: Evidence from a google trends-based Infodemiology study

“…In Italy, dermatological surgery patients in the restricted zone were reduced by approximately more than 45%. 30 This decrement suggests the reason behind the continuous RSVs increment in Italy. Despite the surge of COVID-19 cases and deaths, Russia and Spain the only two countries showed little change in RSVs increment.…”

<p>Patient Satisfaction and Associated Factors During COVID-19 Pandemic in North Shoa Health Care Facilities</p>

“…16 In contrast, the effect of COVID-19 has been reducing procedure and treatment adherence, increase treatment dissatisfaction, and discontinue their treatment follow-up. 17,18 The outcome of unmet client needs can be problematic since it causes a lack of confidence in the healthcare system and healthcare providers. 19,20 In resourced countries, patient needs during COVID-19 can be managed by telemedicine, which is vital to deliver methods of infection control and compliance to social distancing, appropriate use of mask and hand hygiene, or sanitizer.…”

Tetracyclines in COVID ‐19 patients quarantined at home: Literature evidence supporting real‐world data from a multicenter observational study targeting inflammatory and infectious dermatoses

“…Our real‐life data support that TetraC may exert a therapeutic effect on COVID‐19 infection by mitigating mild symptoms. Due to the COVID‐19‐related dermatology overwhelming, several patients with inflammatory and infectious dermatoses were evaluated and treated by distance especially if they display COVID‐19 compatible mild symptoms 11‐15 . In this scenario, TetraC represent an ideal treatment for inflammatory dermatoses for their immunomodulatory properties, bacterial infections for their antibacterial effect and mild forms of COVID‐19 for their antiviral effect.…”